Abstract
Rationale,aims and objectives:The aim of this in vivo study was to
evaluate the clinical 1 year follow-up of silica and flouroapatite
reinforced glass carbomer filling material.Materials and Methods:In this
study, total of 100 restorations were performed.All cavities were
prepared conventionally.Half of the restorations were restored with nano
composite resin (TEP) (Tokuyama Estelite, Tokuyama Dental, Japan) and
the other half were restored with glass carbomer material (GC) (GCP
Dental, The Netherlands). Each restorative material was applied
according to the manufacturer’s instructions. Restorations were
evaluated with modified USPHS criteria at the end of the first week, 6
months and 12 months.Data were analyzed using Fisher’s Exact Chi-Square
test, Fisher Freeman Halton Test and Continuity (Yates)
Correction.Wilcoxon sign test was used for intra-group comparisons of
the parameters.Statistically significance was evaluated at p
<0.05.Results:When the filling materials were compared with
each other, statistically significant difference was observed at the
12th month on the marginal discoloration. Statistically significant
difference was observed between the two materials in the 6th month on
the marginal adaptation (p<0.05).Conclusions:In view of this
results, there is a need to improve the physical properties of the GC
filling material and further in vivo study. Clinical Relevance:Due to
not provide good marginal sealing for Class II cavities, it is suggested
that GC systems are applied to Class I cavities for now. Key Words;
Glass-carbomer; Glass-ionomer cement; Resin composite; Clinical trial
ClinicalTrials.gov Identifier: NCT04127929 (16.10.2019)